EUVIMEDEUVIMED entdecken
Crossref

Simultaneous Targeting of IL-1–Signaling and IL-6–Trans-Signaling Preserves Human Pulmonary Endothelial Barrier Function During a Cytokine Storm—Brief Report

Natalia Colás-Algora, Pablo Muñoz-Pinillos, Cristina Cacho-Navas iD, José Avendaño-Ortiz iD, Gema de Rivas, Susana Barroso, Eduardo López-Collazo, Jaime Millán iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2023

DOI: 10.1161/atvbaha.123.319695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023. Verfasst von Natalia Colás-Algora und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Biología Molecular Severo Ochoa, CSIC-UAM, Cantoblanco, Madrid, Spain (N.C.-A., P.M.-P., C.C.-N., G.d.R., S.B., J.M.). Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, COVID-19, Sepsis. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Systemic inflammatory diseases, such as sepsis and severe COVID-19, provoke acute respiratory distress syndrome in which the pathological hyperpermeability of the microvasculature, induced by uncontrolled inflammatory stimulation, causes pulmonary edema. Identifying the inflammatory mediators that induce human lung microvascular endothelial cell barrier dysfunction is essential to find the best anti-inflammatory treatments for critically ill acute respiratory distress syndrome patients. METHODS: We have compared the responses of primary human lung microvascular endothelial cells to the main inflammatory mediators involved in cytokine storms induced by sepsis and SARS-CoV2 pulmonary infection and to sera from healthy donors and severely ill patients with sepsis. Endothelial barrier function was measured by electric cell-substrate impedance sensing, quantitative confocal microscopy, and Western blot. RESULTS: The human lung microvascular endothelial cell barrier was completely disrupted by IL (interleukin)-6 conjugated with soluble IL-6R (IL-6 receptor) and by IL-1β (interleukin-1beta), moderately affected by TNF (tumor necrosis factor)-α and IFN (interferon)-γ and unaffected by other cytokines and chemokines, such as IL-6, IL-8, MCP (monocyte chemoattractant protein)-1 and MCP-3. The inhibition of IL-1 and IL-6R simultaneously, but not separately, significantly reduced endothelial hyperpermeability on exposing human lung microvascular endothelial cells to a cytokine storm consisting of 8 inflammatory mediators or to sera from patients with sepsis. Simultaneous inhibition of IL-1 and JAK (Janus kinase)-STAT (signal transducer and activator of transcription protein), a signaling node downstream IL-6 and IFN-γ, also prevented septic serum-induced endothelial barrier disruption. CONCLUSIONS: These findings strongly suggest a major role for both IL-6 trans-signaling and IL-1β signaling in the pathological increase in permeability of the human lung microvasculature and reveal combinatorial strategies that enable the gradual control of pulmonary endothelial barrier function in response to a cytokine storm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Distress SyndromeCOVID-19SepsisHumansInterleukin-6Cytokine Release SyndromeEndothelial CellsRNA, ViralLungInterferon-gammaTumor Necrosis Factor-alphaInterleukin-1

Stichwörter der Autor:innen

endothelial cellinterferoninterleukinpermeabilityrespiratory distress syndromesepsis

Substanzen

Interleukin-6RNA, ViralInterferon-gammaTumor Necrosis Factor-alphaInterleukin-1

Autor:innen und Institutionen

  • Centro de Biología Molecular Severo Ochoa, CSIC-UAM, Cantoblanco, Madrid, Spain (N.C.-A., P.M.-P., C.C.-N., G.d.R., S.B., J.M.).
  • The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain (J.A.O., E.L.-C.).
  • CIBER of Respiratory Diseases (CIBERES), Madrid, Spain (J.A.O., E.L.-C.).

ORCID-Profile: Cristina Cacho-Navas, José Avendaño-Ortiz, Jaime Millán

Zitieren

APA

Colás-Algora, N., Muñoz-Pinillos, P., Cacho-Navas, C., Avendaño-Ortiz, J., de Rivas, G., Barroso, S., López-Collazo, E., & Millán, J. (2023). Simultaneous Targeting of IL-1–Signaling and IL-6–Trans-Signaling Preserves Human Pulmonary Endothelial Barrier Function During a Cytokine Storm—Brief Report. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.123.319695

Vancouver

Colás-Algora N, Muñoz-Pinillos P, Cacho-Navas C, Avendaño-Ortiz J, de Rivas G, Barroso S, et al. Simultaneous Targeting of IL-1–Signaling and IL-6–Trans-Signaling Preserves Human Pulmonary Endothelial Barrier Function During a Cytokine Storm—Brief Report. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023. doi:10.1161/atvbaha.123.319695

BibTeX
@article{ColsAlgora2023,
  author = {Colás-Algora, Natalia and Muñoz-Pinillos, Pablo and Cacho-Navas, Cristina and Avendaño-Ortiz, José and de Rivas, Gema and Barroso, Susana and López-Collazo, Eduardo and Millán, Jaime},
  title = {Simultaneous Targeting of IL-1–Signaling and IL-6–Trans-Signaling Preserves Human Pulmonary Endothelial Barrier Function During a Cytokine Storm—Brief Report},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2023},
  doi = {10.1161/atvbaha.123.319695}
}
Kostenlos starten →